- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03881657
Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border
March 18, 2019 updated by: Karen Errichetti, Health Resources in Action, Inc.
Sí Texas: Improving Access to Integrated Care for Rio Grande Valley Residents With Severe & Persistent Mental Illness
This study evaluated whether patients with severe and persistent mental illness (SPMI) who received coordinated co-located behavioral health and primary care services were more likely to improve health outcomes after 12 months compared to SPMI patients who receive only behavioral health services from the local mental health authority (LMHA) Tropical Texas Behavioral Health (TTBH).The study employed a randomized control trial (RCT) design where intervention participants receiving integrated behavioral health were compared to control participants receiving the usual care provided within an LMHA for SPMI patients.
Patients were placed in each group using a randomized number process.
Demographic and health outcome data were collected from intervention and control participants at baseline.
Health outcome data was subsequently collected at 6-month and 12-month follow-up points.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study evaluated whether patients with severe and persistent mental illness (SPMI) who received coordinated co-located behavioral health and primary care services were more likely to improve health outcomes after 12 months compared to SPMI patients who receive only behavioral health services from the local mental health authority (LMHA) Tropical Texas Behavioral Health (TTBH).The study employed a randomized control trial (RCT) design where intervention participants receiving integrated behavioral health were compared to control participants receiving the usual care provided within an LMHA for SPMI patients.
Patients were placed in each group using a randomized number process.
Demographic and health outcome data were collected from intervention and control participants at baseline.
Health outcome data was subsequently collected at 6-month and 12-month follow-up points.
The primary outcome of interest was systolic blood pressure.
Additional secondary outcomes of interest were diastolic blood pressure, HbA1c, BMI, total cholesterol, depressive symptoms, and life functioning.
These outcomes were analyzed as continuous variables using linear regression with backward model selection.
Longitudinal analyses were also conducted using a likelihood-based approach to general linear mixed models.The intervention and control groups were patients with an SPMI diagnosis over 18 years of age who were not receiving primary care services prior to enrollment and were eligible to receive behavioral health services from TTBH.
The participants resided in Cameron or Hidalgo County and had one or more chronic conditions: hypertension (blood pressure of 140/90 mmHg or higher), poorly controlled diabetes (HbA1c over 8.5%), obesity (body mass index of 30.0 or higher), or hypercholesterolemia (total cholesterol level above 200).
Study Type
Interventional
Enrollment (Actual)
416
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Reside in Cameron, Hidalgo, or Willacy County
- Have a severe, persistent mental illness as diagnosed by a licensed behavioral health care provider
- Be eligible to receive behavioral health services from TTBH
- Must not be receiving any primary care outside of TTBH (as ascertained via patient self-report)
- Have a diagnosis of one or more chronic conditions:
- Hypertension (blood pressure of 140/90 mmHg or higher)
- Obesity (body mass index of 30.0 or higher)
- Poorly controlled diabetes (HbA1c over 8.5%)
- Hypercholesterolemia (Total cholesterol level above 200)
Exclusion Criteria:
- Not actively suicidal at time of enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group
The intervention group received a reverse colocated integrated behavioral health intervention or usual care
|
A reverse colocated integrated care model is one where primary care and preventive services are embedded within a behavioral health service setting.
|
ACTIVE_COMPARATOR: Control Group
The control group received behavioral health services only (usual care)
|
Behavioral health services without primary care or integrated care services
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: One year
|
Blood pressure was measured as a continuous variable (systolic and diastolic) in millimeters of mercury (mmHg).
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood glucose concentration
Time Frame: One year
|
Blood glucose concentration was measured via blood test for HbA1c as a continuous variable
|
One year
|
Body mass index
Time Frame: One year
|
Height and weight were measured at baseline, and body mass index was calculated
|
One year
|
Total cholesterol
Time Frame: One year
|
Measured as a continuous variable in milligrams per deciliter
|
One year
|
Depressive symptoms
Time Frame: One year
|
Measured as a score on the Patient Health Questionnaire-9 tool
|
One year
|
Life functioning
Time Frame: One year
|
Measured as a score composite of the Adult Needs and Strengths Assessment Tool
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Errichetti KS, Flynn A, Gaitan E, Ramirez MM, Baker M, Xuan Z. Randomized Trial of Reverse Colocated Integrated Care on Persons with Severe, Persistent Mental Illness in Southern Texas. J Gen Intern Med. 2020 Jul;35(7):2035-2042. doi: 10.1007/s11606-020-05778-2. Epub 2020 Apr 20.
- Sautter Errichetti K, Ramirez MM, Flynn A, Xuan Z. A reverse colocated integrated care model intervention among persons with severe persistent mental illness at the U.S.-Mexico border: A randomized controlled trial protocol. Contemp Clin Trials Commun. 2019 Nov 12;16:100490. doi: 10.1016/j.conctc.2019.100490. eCollection 2019 Dec.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 24, 2015
Primary Completion (ACTUAL)
August 22, 2017
Study Completion (ACTUAL)
August 22, 2017
Study Registration Dates
First Submitted
March 15, 2019
First Submitted That Met QC Criteria
March 18, 2019
First Posted (ACTUAL)
March 19, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 19, 2019
Last Update Submitted That Met QC Criteria
March 18, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 100001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Reverse Colocated Integrated Care
-
Scott & White Health PlanCompletedChronic IllnessUnited States
-
Association De La Msp PasteurNot yet recruiting
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of BaselUniversity of Zurich; KU Leuven; Duke University; Swiss National Science Foundation and other collaboratorsCompleted
-
Umeå UniversitySwedish Association of Local Authorities and RegionsCompletedChronic Heart FailureSweden
-
Universitätsklinikum Hamburg-EppendorfRecruitingSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Delusional Disorder | Psychotic Disorder NOS | Severe Major Depression With Psychotic FeaturesGermany
-
The George Institute for Global Health, ChinaNational Institute of Mental Health (NIMH); Peking University Sixth HospitalCompletedDepression | Acute Coronary SyndromesChina
-
National Taiwan University HospitalRecruiting
-
University Hospital of North NorwayThe Royal Norwegian Ministry of HealthUnknownFrail Elderly w/ Multimorbidity & Functional LimitationsNorway
-
University of Colorado, DenverCompletedChronic Obstructive Pulmonary DiseaseUnited States